A Guide for Vaccinating the IBD Patient and Findings on the Impact of Gluten-Free Diet in Adult Celiac Patients Featured in June Issue of The American Journal of Gastroenterology

Jun 22, 2010, 14:15 ET from American College of Gastroenterology

BETHESDA, Md., June 22 /PRNewswire-USNewswire/ -- A guide for vaccinating the Inflammatory Bowel Disease patient, and studies looking at the impact of a gluten-free diet on adults with celiac disease and the relationship between cognitive factors and treatment response in patients with functional bowel disorders, like IBS, are among the highlights of the June issue of The American Journal of Gastroenterology.

Although advances in therapies for IBD patients have increased the number of infectious complications, IBD patients continue to have poor rates of immunization—and as a result are at greater risk of contracting an infectious disease, according to "A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient," published in the June issue.

The study, "Mucosal Recovery and Mortality in Adults with Celiac Disease After Treatment with a Gluten-Free Diet," found that mucosal recovery was absent in a "substantial portion" of adults with celiac disease years after diagnosis, and that there is a "borderline  significant association" between confirmed mucosal recovery (vs. permanent damage) and reduced mortality.

For medication, psychological, and placebo treatment in functional bowel disorders (FBD), satisfaction with treatment depends on cognitive factors of confidence in treatments, perceived control over illness and symptoms, and reduction in negative cognitions related to symptom experience. The study, "Cognitive Factors Affect Treatment Response to Medical and Psychological Treatments in Functional Bowel Disorders," concluded that addressing these issues among patients with FBD may enhance treatment response to a variety of treatments.

This month's Journal also features a number of other findings, including:

View the Table of Contents and abstracts from the June issue -- including the IBD vaccination guide and the studies cited above--online at The American Journal of Gastroenterology. For full texts, media can contact the ACG at mediaonly@acg.gi.org or 301-263-9000.

About the American College of Gastroenterology

Founded in 1932, the American College of Gastroenterology (ACG) is an organization with an international membership of over 11,000 individuals from 80 countries.   The College is committed to serving the clinically oriented digestive disease specialist through its emphasis on scholarly practice, teaching and research.  The mission of the College is to serve the evolving needs of physicians in the delivery of high quality, scientifically sound, humanistic, ethical and cost-effective health care to gastroenterology patients.  

About The American Journal of Gastroenterology

The American Journal of Gastroenterology is published on behalf of the American College of Gastroenterology by Nature Publishing Group.  As the leading clinical journal covering gastroenterology and hepatology, The American Journal of Gastroenterology (AJG) provides practical and professional support for clinicians dealing with the gastroenterological disorders seen most often in patients.

Published with practicing clinicians in mind, AJG devotes itself to publishing timely medical research in gastroenterology and hepatology.  The Co-Editors-in-Chief are William D. Chey, MD, AGAF, FACG, FACP of the University of Michigan and Paul Moayyedi, BSc, MB ChB, PhD, MPH, FRCP, FRCPC, FACG of McMaster University.

SOURCE American College of Gastroenterology